News

Published on 21 Apr 2024 on Simply Wall St. via Yahoo Finance

Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms...


Article preview image

Key Insights

Significant control over Repare Therapeutics by private equity firms implies that the general public has more power to influence management and governance-related decisions54% of the business is held by the top 5 shareholders Institutional ownership in Repare Therapeutics is 24%

To get a sense of who is truly in control of Repare Therapeutics Inc. (NASDAQ:RPTX), it is important to understand the ownership structure of the business. With 34% stake, private equity firms possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

NASDAQ.RPTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms...

Key Insights Significant control over Repare Therapeutics by private equity firms implies that th...

Simply Wall St. via Yahoo Finance 21 Apr 2024

Repare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023

Revenue: Reported a decrease to $13.0 million in Q4 and $51.1 million for the full year, compared...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Repare Therapeutics Inc. (RPTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Wall Street expects a year-over-year increase in earnings on lower revenues when Repare Therapeut...

Zacks via Yahoo Finance 20 Feb 2024

Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?

Repare Therapeutics Inc. (RPTX) shares ended the last trading session 8.8% higher at $8.41. The j...

Zacks via Yahoo Finance 13 Feb 2024

Repare Therapeutics (RPTX) Rises 34% in a Week: Here's Why

Repare Therapeutics Inc. RPTX is using its genome-wide, CRISPR-enabled SNIPRx platform to discove...

Zacks via Yahoo Finance 22 Nov 2023

Repare Therapeutics Inc. (NASDAQ:RPTX) most popular amongst private equity firms who own 33% of the...

Key Insights The considerable ownership by private equity firms in Repare Therapeutics indicates ...

Simply Wall St. via Yahoo Finance 12 Nov 2023

Repare Therapeutics Inc (RPTX) Reports Q3 2023 Financial Results Amid Pipeline Progress

Repare Therapeutics Inc (NASDAQ:RPTX) presented promising initial data from the Phase 1 MYTHIC cl...

GuruFocus.com via Yahoo Finance 9 Nov 2023

Strength Seen in Repare Therapeutics Inc. (RPTX): Can Its 12.2% Jump Turn into More Strength?

Repare Therapeutics Inc. (RPTX) shares soared 12.2% in the last trading session to close at $12.5...

Zacks via Yahoo Finance 20 Sep 2023

Brokers Are Upgrading Their Views On Repare Therapeutics Inc. (NASDAQ:RPTX) With These New Forecasts

Shareholders in Repare Therapeutics Inc. (NASDAQ:RPTX) may be thrilled to learn that the analysts...

Simply Wall St. via Yahoo Finance 14 Aug 2023

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Tops Revenue Estimates

Repare Therapeutics Inc. (RPTX) came out with a quarterly loss of $0.28 per share versus the Zack...

Zacks via Yahoo Finance 9 Aug 2023